Možné imunologické důsledky B cílené imunoonkologické léčby
| Title in English | ossible immunology consequences of targeted B cell immunooncological therapies |
|---|---|
| Authors | |
| Year of publication | 2018 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Theres is an rising number of secondary antibody deficiency patients after B cell targeted therapies. The patients should be regullary monitored during and after the treatment. Prophylactic antibiotics and IVIG shoul vbe administered when indicated. |
| Related projects: |